1![Flyer06-Pharmaco Imaging_MLI_2012-09.pdf Flyer06-Pharmaco Imaging_MLI_2012-09.pdf](https://www.pdfsearch.io/img/e0660a08b13339802fc62a22df8158c8.jpg) | Add to Reading ListSource URL: www.oncodesign.frLanguage: English - Date: 2012-12-18 04:20:40
|
---|
2![Microsoft Word - Danube_Symposium_2016_flyer.docx Microsoft Word - Danube_Symposium_2016_flyer.docx](https://www.pdfsearch.io/img/0efd645beecdaea90e03d0afc3ffd2ca.jpg) | Add to Reading ListSource URL: chemie.univie.ac.atLanguage: English - Date: 2016-06-21 04:50:54
|
---|
3![In cooperation with Rudolf Öhler / Gerald Stübiger Project Leaders MALDI-MS CBmed Contact: In cooperation with Rudolf Öhler / Gerald Stübiger Project Leaders MALDI-MS CBmed Contact:](https://www.pdfsearch.io/img/3b71ec7d1ec48b03adb42ad130c4f05b.jpg) | Add to Reading ListSource URL: www.cbmed.orgLanguage: English - Date: 2016-07-05 08:05:00
|
---|
4![® Pharmimage A bridge between preclinical and clinical pharmacology. ® Pharmimage A bridge between preclinical and clinical pharmacology.](https://www.pdfsearch.io/img/5158eaeeabc6b4b7bc5c9ebfc1ef98e6.jpg) | Add to Reading ListSource URL: www.oncodesign.frLanguage: English - Date: 2014-02-14 04:37:03
|
---|
5![p-medicine – Grant Agreement noD13.2 Concrete recommendations and findings on selected challenges in the selected diseases Deliverable NoConcrete recommendations and findings on selected challenges in t p-medicine – Grant Agreement noD13.2 Concrete recommendations and findings on selected challenges in the selected diseases Deliverable NoConcrete recommendations and findings on selected challenges in t](https://www.pdfsearch.io/img/e59b73ad75ddb49d53c397c1e63bc113.jpg) | Add to Reading ListSource URL: p-medicine.euLanguage: English - Date: 2013-02-13 06:22:25
|
---|
6![PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer First clinical study evaluating a mutated EGFR-receptor marker in patients using PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer First clinical study evaluating a mutated EGFR-receptor marker in patients using](https://www.pdfsearch.io/img/bcf2d6413c948419cff5aba530f38aab.jpg) | Add to Reading ListSource URL: www.oncodesign.comLanguage: English - Date: 2016-07-12 12:51:48
|
---|
7![MayImproving Trial Success by Improving Tumor Assessment Jamal Gasmi, MD, PhD l Vice President & Global Leader Oncology & Hematology Drug Development, ICON Clinical Research James Conklin, MD, MS l Senior Vice Pre MayImproving Trial Success by Improving Tumor Assessment Jamal Gasmi, MD, PhD l Vice President & Global Leader Oncology & Hematology Drug Development, ICON Clinical Research James Conklin, MD, MS l Senior Vice Pre](https://www.pdfsearch.io/img/bd35262845b37b6a3bfa9f2dd6322402.jpg) | Add to Reading ListSource URL: www.aptivsolutions.comLanguage: English - Date: 2013-08-16 10:39:06
|
---|
8![Science & Society Translational environmental biology: cell biology informing conservation Nikki Traylor-Knowles and Stephen R. Palumbi Department of Biology, Stanford University, Hopkins Marine Station, Pacific Grove, Science & Society Translational environmental biology: cell biology informing conservation Nikki Traylor-Knowles and Stephen R. Palumbi Department of Biology, Stanford University, Hopkins Marine Station, Pacific Grove,](https://www.pdfsearch.io/img/a2fffd8b9a102cf869e8f085084834bf.jpg) | Add to Reading ListSource URL: palumbi.stanford.eduLanguage: English - Date: 2014-04-28 16:50:43
|
---|
9![. IMAGING . BIOMARKERS . PRECLINICAL . PHARMACOLOGY . ONCOLOGY . ONCOCARDIO ASSESSING CARDIOTOXICITY OF ANTICANCER DRUGS . IMAGING . BIOMARKERS . PRECLINICAL . PHARMACOLOGY . ONCOLOGY . ONCOCARDIO ASSESSING CARDIOTOXICITY OF ANTICANCER DRUGS](https://www.pdfsearch.io/img/ca252caf6c72f4d45a98025eaf5efdbb.jpg) | Add to Reading ListSource URL: www.oncodesign.frLanguage: English - Date: 2013-07-03 09:03:43
|
---|
10![Why we focus on Cancer Imaging Imaging plays a crucial role in the clinical management of patients with cancer. Both anatomical (CT/MRI) and Molecular imaging (PET/SPECT) modalities provide essential information on the l Why we focus on Cancer Imaging Imaging plays a crucial role in the clinical management of patients with cancer. Both anatomical (CT/MRI) and Molecular imaging (PET/SPECT) modalities provide essential information on the l](https://www.pdfsearch.io/img/b670b3061e31f9db79a0e045ab1a9194.jpg) | Add to Reading ListSource URL: www.bci.qmul.ac.ukLanguage: English - Date: 2016-04-04 11:36:10
|
---|